Key result
Increasing age was associated with a decreasing ratio of plasma NT-proBNP to BNP in children and adolescents both with and without congenital heart disease.
Why the study?
Does the ratio of NT-proBNP to BNP change with age in children and adolescents with and without congenital heart disease?
Cross-Sectional (n=76)
Does the ratio of NT-proBNP to BNP change with age in children and adolescents with and without congenital heart disease?
The ratio of NT-proBNP to BNP decreases with increasing age in children and adolescents, highlighting the need for age-specific considerations when interpreting these biomarkers in pediatric cardiology.
Answers are grounded in this paper and cite their sources.
Age-adjusted NT-proBNP/BNP ratios may improve interpretation in pediatric cardiac assessment; leaves open need for larger normative studies before routine use.
Background: B‐type natriuretic peptide (BNP) and the N‐terminal fragment of proBNP (NT‐proBNP) seem to be useful diagnostic tools also in children with cardiac disease. Recent data suggest that plasma levels of both peptides show different patterns from infancy to adolescence. Aim: To investigate the relationship of BNP and NT‐proBNP in children and adolescents according to age. Subjects and methods: In 46 individuals without cardiac disease (22 males, 24 females, aged 0.4–17.5 years) and 30 patients with congenital heart disease (17 males, 13 females, aged 0.2–18.4 years), plasma levels of BNP and NT‐proBNP were measured in the same sample (triage BNP assay, Biosite® and Elecsys NT‐proBNP assay, Roche Diagnostics®). Results: The range of BNP plasma levels was 5–32 pg/ml in individuals without heart disease and 5–1300 pg/ml in the patient group, the range of NT‐proBNP was 10–298 pg/ml and 30–18966 pg/ml, respectively. In both groups, the ratio NT‐proBNP/BNP decreased with increasing age ( P <0.001). Conclusion: Although proBNP is cleaved into the two fragments NT‐proBNP and BNP, there is a decreasing ratio of NT‐proBNP/BNP with increasing age caused probably by age‐dependent differences in the metabolic clearance of both peptides. This has to be considered in comparison studies on BNP and NT‐proBNP regarding their benefit to paediatric cardiology.
No takes yet. Share an insight, caveat, or question.
Koch et al. (2006) conducted a cross-sectional in Congenital heart disease (n=76). Increasing age was evaluated on Ratio of NT-proBNP to BNP (p=<0.001). Increasing age was associated with a decreasing ratio of plasma NT-proBNP to BNP in children and adolescents both with and without congenital heart disease.
Synapse has enriched 10 related papers. Consider them for comparative context: